Investor Presentation First Nine Months of 2023

33 Investor presentation First nine months of 2023 Novo NordiskⓇ Novo Nordisk has a global manufacturing setup Local production All products API, fill and finish Russia API, fill and finish Fill and finish Product Fill and finish Iran Algeria Fill and finish ㅎ API ň பப் ஆ Filling / tableting Supply value chain Research and Development Manufacturing development production API: Active Pharmaceutical Ingredient Japan Assembly and packaging Distribution (cold chain) Patients

View entire presentation